CG
LKFT

Cutler Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Cutler Group’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-345
Closed -$12.8K – 2748
2023
Q4 		$14K Buy
+345
New +$12.7K ﹤0.01% 2180
2022
Q3 		– Sell
-3,424
Closed -$191K – 5120
2022
Q2 		$191K Buy
3,424
+390
+13% +$23.1K 0.01% 1037
2022
Q1 		$188K Sell
3,034
-4,766
-61% -$292K 0.01% 1237
2021
Q4 		$430K Sell
7,800
-21,920
-74% -$1.14M 0.02% 827
2021
Q3 		$1.56M Buy
29,720
+3,420
+13% +$203K 0.07% 301
2021
Q2 		$1.81M Buy
26,300
+6,650
+34% +$507K 0.08% 266
2021
Q1 		$1.51M Buy
19,650
+17,850
+992% +$1.64M 0.07% 294
2020
Q4 		$178K Buy
1,800
+1,700
+1,700% +$208K 0.01% 1150
2020
Q3 		$14K Sell
100
-657
-87% -$110K ﹤0.01% 2733
2020
Q2 		$149K Sell
757
-93
-11% -$19.3K 0.01% 1040
2020
Q1 		$166K Buy
850
+450
+113% +$96.8K 0.01% 1067
2019
Q4 		$82K Sell
400
-400
-50% -$73.9K 0.01% 1306
2019
Q3 		$122K Buy
800
+400
+100% +$65.5K 0.01% 962
2019
Q2 		$51K Buy
+400
New +$47.5K ﹤0.01% 1530
2018
Q4 		– Sell
-933
Closed -$94.6K – 4164
2018
Q3 		$104K Sell
933
-1,367
-59% -$144K 0.01% 1172
2018
Q2 		$212K Buy
2,300
+1,500
+188% +$146K 0.02% 752
2018
Q1 		$79K Buy
800
+300
+60% +$32.3K 0.01% 1351
2017
Q4 		$46K Sell
500
-100
-17% -$9.46K ﹤0.01% 1929
2017
Q3 		$61K Sell
600
-2,719
-82% -$238K ﹤0.01% 2057
2017
Q2 		$253K Buy
+3,319
New +$279K 0.01% 1103
2017
Q1 		– Sell
-100
Closed -$7.2K – 6653
2016
Q4 		$6K Buy
+100
New +$6.15K ﹤0.01% 4741

Other funds holding LKFT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cutler Group's LKFT Position: Q1 2024 in Review

Cutler Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2024, closing a stake of 345 shares — an estimated $12.8K sold.

Cutler Group first reported a position in LKFT in Q4 2016 and held it in 21 quarters. The position peaked at $1.81M in Q2 2021. 82 funds tracked by Wall St. Rank hold LKFT as of Q1 2024.

  • Cutler Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 345 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2024, an estimated $12.8K.
  • Cutler Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and held it in 21 quarters.
  • Cutler Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.81M in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.